Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment
1. The FDA approved orforglipron (Foundayo) on April 1, 2026, making it the first non-peptide oral GLP-1 receptor agonist cleared...
1. The FDA approved orforglipron (Foundayo) on April 1, 2026, making it the first non-peptide oral GLP-1 receptor agonist cleared...
1. A University of Calgary study published in Science Advances this month found that chronic wasting disease can spread silently...
1. A June 2026 NPR investigation found the commercial gut microbiome market has run far ahead of what the science...
1. University of Florida researchers found that glucosamine, the popular joint supplement taken by tens of millions of older Americans,...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers....
1. TikTok’s “cortisol face” trend has led more patients to request cortisol testing for facial puffiness, weight gain, or stress-related...
1. Reports of emotional flattening among some users of semaglutide (Ozempic) have brought new attention to how glucagon-like peptide-1 receptor...
1. An Andes virus outbreak aboard the MV Hondius expedition cruise ship led to severe respiratory illness, multiple deaths, and...
1. Celebrity endorsements have helped turn whole-body magnetic resonance imaging into a high-cost consumer screening trend for asymptomatic adults. 2....
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers....
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.